Fusobacterium nucleatum通过表观遗传现象决定了胺诱导的行为反应的表达
Samuel J Mabry1, Xixi Cao2, Yanqi Zhu1
1University of Alabama Birmingham, Department of Surgery, Birmingham, Alabama.
bioRxiv : the preprint server for biology
|January 27, 2025
概括
细菌Fusobacterium nucleatum及其副产品丁酸盐通过增加多巴胺转运体表达来增强安非他命 (AMPH) 作用,这表明用于治疗AMPH使用障碍 (AUD) 的微生物点.
科学领域:
- 微生物学与神经科学 微生物学与神经科学
- 肠-大脑轴研究研究
- 药理学 药理学是指药理学的学科.
背景情况:
- 胺类药物 (AMPHs) 是具有治疗用途和高滥用潜力的精神兴奋剂,导致胺使用障碍 (AUD).
- 肠道功能障碍症与AUD的发病有关,但具体的微生物机制尚不清楚.
- 在老鼠和人类中,Fusobacterium nucleatum (Fn) 的丰富性随着AMPH暴露而增加.
研究的目的:
- 调查Fn及其副产品短链脂肪酸 (SCFA) 丁酸盐在AMPH的行为影响中的机械作用.
- 为了探索基因组脱乙酶1 (HDAC1) 在Fn介导的AMPH强化中的参与.
- 阐明Fn和丁酸盐对多巴胺转运器 (DAT) 功能和胺诱导行为的影响.
主要方法:
- 基因生物Drosophila melanogaster模型被Fn殖民或补充了丁酸盐.
- 使用RNA干扰 (RNAi) 抑制了HDAC1.
- 行为测试测量了AMPH诱导的精神运动活动,奖励和性动机.
- 分析了多巴胺 (DA) 载体的功能和表达.
主要成果:
- Fn殖民或酸盐补充剂增强了AMPH在Drosophila中的精神运动,奖励和男性性激励效应.
- 仅仅抑制HDAC1就能模仿这些增强AMPH的效果.
- 酸,酸盐和HDAC1抑制增加了AMPH诱导的非膀性DA释放 (NVDR) 通过上调DAT表达.
结论:
- Fusobacterium nucleatum通过释放丁酸盐,抑制HDAC1并调节DAT表达,从而导致安非他命使用障碍.
- 这种机制通过增加多巴胺载体功能来增强AMPH的精神运动和奖励效应.
- 这些发现将Fn确定为微生物点,并建议在AUD治疗中使用益生菌干预措施.
相关概念视频
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
158
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
158
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Drugs Affecting Neurotransmitter Release or Uptake
929
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
929
Drug Abuse and Addiction: Pharmacological Phenomena
432
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
432


